1.28
36.46%
0.342
Xilio Therapeutics Inc (XLO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.55%
17.49
|
18.13 | 17.36 | 20.12 | 23.53 |
Operating Income/Loss |
3.55%
-17.49
|
-18.13 | -17.36 | -20.12 | -23.53 |
Nonoperating Income/Loss |
40.21%
0.284
|
0.475 | 0.613 | 0.761 | 0.88 |
Income/Loss From Continuing Operations Before Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
Income/Loss From Continuing Operations After Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
Net Income/Loss
|
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
135.87K%
27.91
|
0.0205 | 27.52 | 27.47 | 27.43 |
Basic Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
Diluted Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):